HORMONE RECEPTOR-POSITIVE NEOPLASMS

Clinical trials for HORMONE RECEPTOR-POSITIVE NEOPLASMS explained in plain language.

Never miss a new study

Get alerted when new HORMONE RECEPTOR-POSITIVE NEOPLASMS trials appear

Sign up with your email to follow new studies for HORMONE RECEPTOR-POSITIVE NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New pill aims to outsmart resistant cancers

Disease control Completed

This early-stage trial tested a new drug called Z-Endoxifen in adults whose hormone-linked cancers had stopped responding to standard treatments. The study aimed to find a safe daily dose and see if the drug could slow or stop tumor growth. It involved 40 people with specific can…

Matched conditions: HORMONE RECEPTOR-POSITIVE NEOPLASMS

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

HORMONE RECEPTOR-POSITIVE NEOPLASMS

Get alerted when new HORMONE RECEPTOR-POSITIVE NEOPLASMS trials appear

New pill aims to outsmart resistant cancers